BIT 0.00% 5.5¢ biotron limited

Corona Virus E Protein as a vaccine target, page-25

  1. 2,841 Posts.
    lightbulb Created with Sketch. 2404
    Colingray

    as much as I love your research, I think you've dropped the ball on your vaccine idea as being the first cab off the rank. Yes, a vaccine is urgently necessary, but it won't prevent a cure from being developed beforehand.

    Biotron will release their test results soon, which ARE compounds for antivirals. If the results are positive - and we can expect that they will be for reasons that do not require repeating - then they'll be advancing on an antiviral cure directly.

    The question outstanding is that what I raised in the first post of this thread. Can their technology be adapted to creating a vaccine too? The literature says it can.

    So, I believe the conversation will go more like this:

    Nerd 1: Wow, another ion channel closes with this cinnamoyleguanidine shit. Let's try one of the derivatives.
    Nerd 2: Why? We've done it a hundred times all ready and the outcome is always the same.
    Nerd 2: OK, put it in the antiviral bottle and clean up. Lets get a cuppa.
    (30 seconds later with burnt lips)
    Nerd 1: Pass me that mouse so that I can give it a jab with this attenuated vaccine candidate.
    Nerd 2: Gee man, not another mouse. We've pricked a hundred already with that E Protein with the missing amino acids, and every mouse recovers when we give it a full blast.
    Last edited by Batmansdaughter: 03/04/20
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
0.000(0.00%)
Mkt cap ! $49.62M
Open High Low Value Volume
5.5¢ 5.6¢ 5.4¢ $20.29K 370.8K

Buyers (Bids)

No. Vol. Price($)
1 17000 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 50922 1
View Market Depth
Last trade - 15.45pm 06/06/2024 (20 minute delay) ?
Last
5.5¢
  Change
0.000 ( 1.79 %)
Open High Low Volume
5.5¢ 5.5¢ 5.4¢ 89292
Last updated 15.45pm 06/06/2024 ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.